Outcomes of Couples After Failed PGD Management: A Single-Center Study at the Paris PGD Center (Antoine Béclère - Necker)
Recruiting now
Conditions studied: Infertility
In brief
Preimplantation genetic testing (PGT) is a reproductive genetic technique aimed at preventing the transmission of severe genetic disorders. In France, its use is strictly regulated and reserved for complex medical situations, often associated with challenging reproductive histories and significant psychological burden. Despite scientific advances, success rates in preimplantation genetic testing remain limited, making the care pathway a significant source of uncertainty regarding the future of the parental project.
Key facts
- Study ID
- NCT07371312
- Run by
- Assistance Publique - Hôpitaux de Paris
- People needed
- 900
- Starts
- 2026-03-25
- Expected to finish
- 2028-03-25
- Last updated by the study team
- 2026-04-21
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Woman belonging to a couple who initiated at least one ovarian stimulation cycle for IVF (± ICSI) with preimplantation genetic diagnosis (PGD).
- No further PGD-related procedures (oocyte retrieval or embryo transfer) performed in the center after December 31, 2022.
- No live-born child resulting from PGD care.
- Woman who expressed her free and informed non-opposition to participation.
You may not qualify if…
- One or more live-born children resulting from PGD care in the center.
- PGD involving gamete donation.
Where it is running
- Hôpital Antoine Béclère — Clamart, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.